Moreau P, Attal M, Hulin C, et al. Phase 3 randomized study of daratumumab + bortezomib/thalidomide/dexamethasone (D-VTD) versus VTD in transplant-eligle newly diagnosed multiple myeloma: part 1 CASSIOPEIA results. 24th Congress of EHA, abstract S145.
Positief advies vergoeding etranacogene dezaparvovec (Hemgenix) voor behandeling hemofilie B
jul 2024 | Benigne hematologie